Single direct oral anticoagulant therapy in stable patients with atrial fibrillation beyond 1 year after coronary stent implantation.

Young ChoiYunhee LeeSung-Hwan KimSunhwa KimJu Youn KimTae-Seok KimYoumi HwangJi-Hoon KimSung-Won JangMan Young LeeYong-Seog Oh

Published in: Heart (British Cardiac Society) (2021)

DOAC monotherapy showed similar efficacy in preventing ischaemic events and was associated with lower major bleeding events compared with combination therapy in patients with AF beyond 1 year after coronary stent implantation.

Keyphrases

combination therapy
atrial fibrillation
coronary artery disease
coronary artery
direct oral anticoagulants
venous thromboembolism
aortic stenosis
clinical trial
randomized controlled trial
stem cells
open label
aortic valve
left ventricular